10.2 Ethical issues in clinical trials and research

Clinical trials are crucial for advancing healthcare, but they come with complex ethical challenges. Researchers must balance scientific rigor with participant safety and rights, adhering to guidelines like informed consent and protecting vulnerable groups.

Ethical oversight, data integrity, and managing conflicts of interest are key to maintaining research integrity. Trial design must consider placebo use, adaptive methods, and ensuring equitable access to benefits, including post-trial treatment and expanded access programs.

Ethical Principles and Guidelines

Fundamental Ethical Principles in Research

Top images from around the web for Fundamental Ethical Principles in Research

• 

  Frontiers | Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future ... View original

  Is this image relevant?

• 

  Ethical principles and placebo-controlled trials – interpretation and implementation of the ... View original

  Is this image relevant?

• 

  Frontiers | Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future ... View original

  Is this image relevant?

• 

  Ethical principles and placebo-controlled trials – interpretation and implementation of the ... View original

  Is this image relevant?

1 of 2

Top images from around the web for Fundamental Ethical Principles in Research

• 

  Frontiers | Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future ... View original

  Is this image relevant?

• 

  Ethical principles and placebo-controlled trials – interpretation and implementation of the ... View original

  Is this image relevant?

• 

  Frontiers | Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future ... View original

  Is this image relevant?

• 

  Ethical principles and placebo-controlled trials – interpretation and implementation of the ... View original

  Is this image relevant?

1 of 2

• Informed consent ensures participants voluntarily agree to participate after understanding risks and benefits
  • Requires clear communication of study purpose, procedures, and potential outcomes
  • Participants must have capacity to make decisions and be free from coercion
  • Includes right to withdraw at any time without consequences
• Helsinki Declaration establishes ethical guidelines for medical research involving human subjects
  • Adopted by World Medical Association in 1964, regularly updated
  • Emphasizes protection of research participants' rights and well-being
  • Outlines responsibilities of researchers and sponsors
• Belmont Report identifies three core ethical principles for human subject research
  • Respect for persons acknowledges individual autonomy and protects those with diminished autonomy
  • Beneficence maximizes benefits and minimizes harm to research participants
  • Justice ensures fair distribution of research benefits and burdens across populations

Protecting Vulnerable Populations

• Vulnerable populations require additional safeguards in research due to increased risk of exploitation or harm
  • Includes children, prisoners, pregnant women, mentally disabled persons, economically disadvantaged
• Special considerations for vulnerable populations in research
  • Enhanced consent processes (parental consent for minors)
  • Additional review by ethics committees
  • Justification for inclusion of vulnerable groups in study design
• Balancing protection of vulnerable groups with equitable access to research benefits
  • Ensuring representation in clinical trials to generate relevant data
  • Implementing culturally sensitive research practices

Research Oversight and Integrity

Institutional Review and Ethical Oversight

• Institutional Review Boards (IRBs) review and approve research protocols involving human subjects
  • Composition includes scientists, non-scientists, and community members
  • Evaluate risks and benefits, informed consent procedures, and participant selection
  • Conduct ongoing monitoring of approved studies
• Data integrity ensures accuracy and consistency of research data throughout its lifecycle
  • Implementing proper data collection, storage, and analysis methods
  • Using electronic data capture systems with audit trails
  • Conducting regular quality control checks and data validation

Managing Conflicts and Biases

• Conflict of interest arises when personal or financial interests could compromise research objectivity
  • Researchers must disclose potential conflicts to institutions and journals
  • Institutions implement policies to manage and mitigate conflicts (recusal from certain decisions)
• Publication bias occurs when study results influence likelihood of publication
  • Tendency to publish positive results more frequently than negative or inconclusive findings
  • Can lead to overestimation of treatment effects in literature
  • Addressing through pre-registration of clinical trials and publication of all results

Clinical Trial Design and Access

Ethical Considerations in Trial Design

• Placebo-controlled trials compare new treatments against inactive substances
  • Raises ethical concerns when effective treatments already exist
  • Must justify use of placebos based on scientific necessity and minimal risk to participants
  • Alternatives include active-control trials or add-on designs
• Adaptive trial designs allow modifications based on interim data analysis
  • Can improve efficiency and reduce participant exposure to ineffective treatments
  • Requires careful planning and statistical expertise to maintain trial integrity

Ensuring Equitable Access to Trial Benefits

• Post-trial access provides continued treatment to participants after study completion
  • Particularly important for life-saving or life-extending treatments
  • Challenges include funding, logistics, and regulatory considerations
  • Researchers and sponsors should plan for post-trial access during study design phase
• Expanded access programs allow use of investigational drugs outside clinical trials
  • Provides treatment options for patients with serious conditions lacking alternatives
  • Balances early access with need for rigorous efficacy and safety data
  • Requires careful consideration of risks, benefits, and fairness in patient selection